Lipid Disorders
Conference Coverage
Gas-filled gastric balloons achieve weight loss
A system that utilizes gas-filled gastric balloons helped obese people lose almost twice as much weight, compared with lifestyle modifications.
Conference Coverage
Beloranib reduces weight in Prader-Willi syndrome, but concerns remain
Key clinical point: Beloranib produces significant weight loss in patients with Prader-Willi syndrome, but concerns have arisen about associated...
News
Strong gender difference for stroke in diabetes patients with restless legs syndrome
CHICAGO – Diabetic women with restless legs syndrome face a sharply elevated risk of stroke.
Conference Coverage
VIDEO: Childhood obesity, particularly severe obesity, is not declining
BALTIMORE – A study of National Health and Nutrition Examination Survey data from 1999 to 2014 shows that rates of childhood obesity are not...
Conference Coverage
Sitagliptin does not reduce liver fat in NAFLD
Key clinical point: Sitagliptin did not reduce liver fat in patients with early diabetes and nonalcoholic fatty liver disease. Major finding: The...
News
No rise in serious HF seen in patients taking saxagliptin or sitagliptin
Key clinical point: No increase in the risk of hospitalization for heart failure was found in a large cohort study that used an FDA surveillance...
Conference Coverage
ACCELERATE: Evacetrapib’s clinical failure sinks lipid-drug class
Key clinical point: Despite producing dramatically beneficially changes in lipid levels, treatment with evacetrapib failed to produce clinical...
Conference Coverage
STAMPEDE: Metabolic surgery bests medical therapy long term
CHICAGO – The superiority of metabolic surgery over intensive medical therapy for achieving glycemic control in patients with type 2 diabetes, as...
News
New analysis bolsters metformin as first line in type 2 diabetes
Key clinical point: Clinical trial data support the use of metformin monotherapy, as opposed to sulfonylurea monotherapy, as a first-line therapy...
Conference Coverage
Ticagrelor cuts post-MI events in diabetes patients
Key clinical point: Among post-MI patients with diabetes, dual-antiplatelet therapy with aspirin and ticagrelor produced a significant drop in the...